Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/15/2003CN1448135A High potency antiseptic composite medicine
10/15/2003CN1448134A Adaptation of anethole trithione for use in prep.of medicine
10/15/2003CN1448133A Daphnetin and arteannuin derivative compatible anti-malaria composition
10/15/2003CN1448132A Modified antineoplastic preparation based on Paclitaxel
10/15/2003CN1448131A Medicine composition containing alpha-pinene and 1,8-eucalyptol fever-tree oil and use thereof
10/15/2003CN1448130A Application of curcumin for treating myodystrophy
10/15/2003CN1448129A Garlicin and garlic oil cyclodextrin derivatives inclusion compound and method for making same
10/15/2003CN1448128A Process for producing nanoparticles of paclitaxel and albumin
10/15/2003CN1448123A Non-spherical and non-platelet pyrithione salts
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124279C Platinum complex, its preparation and therapeutic application
10/15/2003CN1124278C Platinum complex, its preparation and therapeutic application
10/15/2003CN1124276C Rapamycin derivatives
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124269C Substituted pryimidine compounds and their use
10/15/2003CN1124266C Azacyclooctane and heptane derivatives, their preparation and usein therapy
10/15/2003CN1124262C Indole derivatives useful as endothelin receptor antagonists
10/15/2003CN1124260C Para retinoic acid
10/15/2003CN1124258C Substituted dihydropyridine dicarboxylic ester
10/15/2003CN1124255C Inhibition of matrix metalloproteases by substituted phenethyl compounds
10/15/2003CN1124157C Pharmaceutical compositions
10/15/2003CN1124153C Medicinal composition for restoring cardiac collaterals and its application
10/15/2003CN1124137C Condensation polymer composition for preventing pregnancy
10/15/2003CN1124136C Drug containing methotrexate derivative
10/15/2003CN1124135C Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/15/2003CN1124134C Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preven
10/15/2003CN1124133C Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and pre
10/15/2003CN1124132C Antibacterial/bactericidal/antiseptic agent, dermatologic preparation and detergent composition
10/15/2003CN1124130C Pharmaceutical preparation comprising colodronate as active ingredient and silicified microcrystalline cellulose as excipient
10/15/2003CN1124129C Solid foamed active substance preparations
10/15/2003CA2381830A1 Compositions comprising thylakoids useful in the modulation of the inflammation process
10/14/2003US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632946 Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632939 Dissolving in alcohol; synthetic blood
10/14/2003US6632933 Use of azetidinone compounds
10/14/2003US6632929 Avidin derivatives and uses thereof
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632845 Method for improving muscle control and muscle tone and improving sensory integration
10/14/2003US6632843 Treatment of bruxism
10/14/2003US6632842 Reducing medication error and enhancing therapeutic compliance of an individual suffering from COPD by providing a single use inhaler
10/14/2003US6632841 Not in the form of cyclodextrin inclusion complex; in solution with lactic acid as solubilizer
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632838 Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia
10/14/2003US6632837 Administered once daily for treatment of neoplastic condition
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632834 Compositions and methods for treating conditions responsive to estrogen
10/14/2003US6632832 Inhibiting epidermal growth factor dependent proliferation in cancer cells
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
10/14/2003US6632827 Compositions of optically pure (+) norcisapride
10/14/2003US6632826 Carbocyclic HIV protease inhibitors
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632824 Have the ability to act at the 5-HT transporter.
10/14/2003US6632823 Substituted pyridine compounds useful as modulators of acetylcholine receptors
10/14/2003US6632822 Compounds and therapeutic methods
10/14/2003US6632821 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
10/14/2003US6632820 Anticancer agents
10/14/2003US6632819 Antiviral azaindole derivatives
10/14/2003US6632818 Inhibitors of prenyl-protein transferase
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/14/2003US6632813 6-subtituted-7-heteroquinoxalinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
10/14/2003US6632812 Substituted lactams as inhibitors of Aβ protein production
10/14/2003US6632811 Administering cycloalkyl, lactam, lactone compounds for for inhibiting beta -amyloid peptide release and/or its synthesis in a cell
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003US6632808 Alzheimer's disease and type 2 diabetes
10/14/2003US6632807 (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide
10/14/2003US6632806 Administering compound having selective GABAc receptor antagonist activity
10/14/2003US6632804 Therapeutically effective amount of ferrous ion and a therapeutically effective amount of an ascorbate
10/14/2003US6632803 Pharmaceutical formulations containing voriconazole
10/14/2003US6632801 Method and composition for inhibiting human cholesterol esterase
10/14/2003US6632799 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
10/14/2003US6632798 Methods for inhibiting angiogenesis
10/14/2003US6632797 Administering to a mammal a cyclic compound (acyclic, carbocyclic or heterocyclic) substituted by at least three vicinal phosphorus containing radicals for treating angiogenesis in tumor conditions
10/14/2003US6632796 Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof
10/14/2003US6632795 Treatment of cancer
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632789 Contacting with inhibitor or activator of phosphatidylinositol 3-kinase
10/14/2003US6632671 Nanoparticle encapsulation system and method
10/14/2003US6632667 Using a antisense oligonucleotides targeted to a untranslated region or a stop codon region of a nucleic acid; use in treatment of Crohn's disease, diabetes, multiple sclerosis, rheumatoid arthritis, hepatitis, pancreatitis and asthma
10/14/2003US6632664 Foreign gene inserted into an untranslated region in the genome
10/14/2003US6632648 Methods of terminal sterilization of fibrinogen
10/14/2003US6632460 Treating angina pectoris, reducing the usage of nitroglycerin
10/14/2003US6632459 For prophylaxis and therapy of diseases, infections
10/14/2003US6632455 Molecular dispersion composition with enhanced bioavailability
10/14/2003US6632454 Multilayer pharmaceutical product for release in the colon
10/14/2003US6632453 Ciprofoxacin-metronidazole antibiotic composition
10/14/2003US6632452 Medicinal compositions retarded in the discoloration of phenolic hydroxyl compounds
10/14/2003US6632449 Compositions and kits comprising a defined boron compound and methods of their preparation
10/14/2003US6632447 Estrogen receptor modulator (SERM): Tamoxifen Citrate and Raloxifene, and Faslodex (Antiestrogen), reducing the amount of high grade prostate intraepithelial neoplasia lesions
10/14/2003US6632443 Water-soluble compositions of bioactive lipophilic compounds
10/14/2003US6632441 Mutants of streptococcal toxin a and methods of use
10/14/2003US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003US6632423 To prevent or reduce fibrosis and/or adhesion in traumatized tissues, comprising the administration of a stabilizing effective amount of the agent to the traumatized tissue
10/14/2003US6632419 Increasing libido in humans via acute testosterone administration